Ingrid Goldberg | Director of Investor Relations |
Michael Minogue | Chairman, President and Chief Executive Officer |
Robert Bowen | Consultant |
Christopher Pasquale | Guggenheim Securities LLC |
Christopher Cooley | Stephens Inc. |
Rajbir Denhoy | Jefferies LLC |
Matthew O'Brien | Piper Jaffray & Co. |
Bruce Nudell | SunTrust Robinson Humphrey, Inc. |
Danielle Antalffy | Leerink Partners LLC |
Malgorzata Kaczor | William Blair & Company LLC |
Jaypreet Chadha | Morgan Stanley & Co. LLC. |
Jayson Bedford | Raymond James & Associates, Inc. |
Good day, ladies and gentlemen, and welcome to the Q3 2018 Abiomed Incorporated Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will follow at that time. [Operator Instructions] As a reminder, this conference call may be recorded. I would now like to introduce your host for today's conference, Ingrid Goldberg, Director of Investor Relations.